Neuroprotection as approach to stroke therapy has recently seen a revival of sorts, fueled in part by the
continuing necessity to improve acute stroke care, and in part by the identification of novel drug targets. 12/15-
Lipoxygenase (12/15-LOX), one of the key enzymes of the arachidonic acid cascade, contributes to both neuronal cell
death and vascular injury. Inhibition of 12/15-LOX may thus provide multifactorial protection against ischemic injury.
Targeting 12/15-LOX and related eicosanoid pathways is the subject of this brief review.
Keywords: Ischemic stroke, neuroprotection, oxidative stress, eicosanoid, lipoxygenase, arachidonic acid cascade.
open access plus
Rights & PermissionsPrintExport